Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2014
09/16/2014CA2712634C Methods and compositions using klotho-fgf fusion polypeptides
09/16/2014CA2575513C Composition comprising a pulmonary surfactant and a tnf-derived peptide
09/16/2014CA2526240C 7a5/prognostin and use thereof for the diagnostic and therapy of tumors
09/16/2014CA2504532C Botulinum neurotoxin b receptors and use thereof
09/16/2014CA1341640C Recombinant fibroblast growth factors
09/12/2014WO2014138725A1 Methods and compositions for the treatment and/or prevention of type 1 diabetes
09/12/2014WO2014138687A1 Peptides and compositions for treatment of joint damage
09/12/2014WO2014138682A1 Compositions and methods for cardiac tissue repair
09/12/2014WO2014138556A1 Kits and methods for the treatment of cancer using gliadin peptides
09/12/2014WO2014138502A1 Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
09/12/2014WO2014138429A2 Peptidomimetic macrocycles and use thereof in regulating hif1alpha
09/12/2014WO2014138374A1 Oral combination therapy for treating hcv infection in specific patient sub-population
09/12/2014WO2014138347A1 Stable solutions of sacrosidase
09/12/2014WO2014138290A1 Compositions and methods for treating bacterial infections
09/12/2014WO2014137997A1 Exercise-regulated adipokines as therapy for diabetes management
09/12/2014WO2014137946A1 Methods of inhibiting igf-1r activation or downtream signalling thereof to reduce radiation-induced cellular senescence
09/12/2014WO2014137869A1 Hepatitis c virus inhibitors
09/12/2014WO2014137572A1 Regulation of specific spinal neurons regulating pain transmission
09/12/2014WO2014137229A2 Neural regeneration peptides and uses therefor
09/12/2014WO2014136932A1 Anti-inflammatory agent
09/12/2014WO2014136931A1 Infection protection agent
09/12/2014WO2014136814A1 Novel peptide having 5 linked ctl epitopes
09/12/2014WO2014136453A1 C12orf48 PEPTIDES AND VACCINES CONTAINING THE SAME
09/12/2014WO2014136118A1 Treatment of post-traumatic stress disorder with melanocortin receptor antagonist
09/12/2014WO2014136116A1 Lipid conjugates in the treatment of bronchitis
09/12/2014WO2014136100A1 Modified poly(beta-amino ester)s for drug delivery
09/12/2014WO2014136081A1 Surgical methods employing purified amphiphilic peptide compositions
09/12/2014WO2014135694A1 Treatment and prevention of remote ischemia-reperfusion injury
09/12/2014WO2014135689A2 Powder formulation
09/12/2014WO2014135622A2 Treatment and prophylaxis of radiation dermatitis
09/12/2014WO2014107745A9 Metal sensitive mutants of matrix metalloproteases and uses thereof
09/11/2014US20140257516 Connective-Tissue-Based or Dermal-Tissue-Based Grafts/Implants
09/11/2014US20140257238 Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
09/11/2014US20140256788 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field
09/11/2014US20140256655 Products and methods for aortic abdominal aneurysm
09/11/2014US20140256653 Whey protein micelles to enhance muscle mass and performance
09/11/2014US20140256652 Polypeptides Involved In Immune Response
09/11/2014US20140256647 Kits and methods for the treatment of cancer using gliadin peptides
09/11/2014US20140256644 Treatment of Muscular Conditions and Muscular Dystrophies
09/11/2014US20140256643 Peptides and compositions for treatment of joint damage
09/11/2014US20140256642 Treatment of degenerative joint disease
09/11/2014US20140256634 Treatments for Gastrointestinal Disorders
09/11/2014US20140256633 Relaxin Proteins For Use In The Diagnosis, Prevention or Treatment of Multiple Sclerosis
09/11/2014US20140256632 Methods useful in the treatment of bone resorption diseases
09/11/2014US20140256631 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
09/11/2014US20140256629 Use of epo-derived peptide fragments for the treatment of neurodegenerative disorders
09/11/2014US20140256627 Methods of delivering pharmaceutical agents
09/11/2014US20140256624 Pharmaceutical composition, methods for treating and uses thereof
09/11/2014US20140256622 Exogenously triggered controlled release materials and uses thereof
09/11/2014US20140256617 In Situ Forming Hydrogel and Method Using Same
09/11/2014US20140256616 Modified green tea polyphenol formulations
09/11/2014US20140256613 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
09/11/2014US20140255518 Treatment and Prevention of Gastrointestinal Syndrome
09/11/2014US20140255513 Lytic domain fusion constructs and methods of making and using same
09/11/2014US20140255504 Enhancement of the efficacy of therapeutic proteins
09/11/2014US20140255487 Dosage form for insertion into the mouth
09/11/2014US20140255485 Collagen hydrolysate and use thereof
09/11/2014US20140255481 Pharmaceutical Compositions for Oral Administration of Insulin Peptides
09/11/2014US20140255477 Compositions and Methods for Delivery of High-Affinity Oxygen Binding Agents to Tumors
09/11/2014US20140255470 Multivalent liposome formulations
09/11/2014US20140255469 Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis
09/11/2014US20140255468 Modified polynucleotides encoding programmed cell death 1
09/11/2014US20140255467 Modified polynucleotides encoding cytotoxic t-lymphocyte-associated protein 4
09/11/2014US20140255426 Wnt pathway inhibitors for treating viral infections
09/11/2014US20140255419 Method of Treating Stress Hyperglycemia with Human Antibodies to the Glucagon Receptor
09/11/2014US20140255400 Arginine-free tnfr:fc-fusion polypeptide compositions and methods of use
09/11/2014US20140255396 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/11/2014US20140255384 Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin
09/11/2014US20140255383 Recombinant human naglu protein and uses thereof
09/11/2014US20140255381 Glucosylceramide synthase inhibitors
09/11/2014US20140255380 Methods of administering 3, 4-diaminopyridine
09/11/2014US20140255379 Stabilized compositions against ionising radiation
09/11/2014US20140255365 Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof
09/11/2014US20140255361 Estrogen-receptor based ligand system for regulating protein stability
09/11/2014US20140255358 Generation of immunosuppressive myeloid cells using pge2
09/11/2014US20140255355 Methods for treating blepharitis
09/11/2014US20140255347 Macrocyclic Inhibitors Of Hepatitis C Virus
09/11/2014US20140255341 Tumor Selective Chemokine Modulation
09/11/2014US20140255337 Methods of treating cognitive impairment
09/11/2014US20140255310 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression
09/11/2014US20140255300 FAP-Activated Proteasome Inhibitors for Treating Solid Tumors
09/11/2014US20140255299 Methods and Compositions Comprising a C-Terminal Bax Peptide
09/10/2014EP2774935A1 Improved neurturin molecules
09/10/2014EP2774620A1 Method for modulating weight loss
09/10/2014EP2773964A1 Method for determination of pharmacological properties of recombinant proteins
09/10/2014EP2773696A1 Self-assembled composite ultrasmall peptide-polymer hydrogels
09/10/2014EP2773675A1 Quick-acting insulin formulation including an oligosaccharide
09/10/2014EP2773673A1 Fusion protein comprising c-terminal domain of ret protein and use thereof as a diagnosing marker
09/10/2014EP2773427A2 Medical use
09/10/2014EP2773376A1 Polyethylene glycol based prodrug of adrenomedullin and use thereof
09/10/2014EP2773369A1 Compositions and methods for preventing and treating oral diseases
09/10/2014EP2773368A1 Inhibition of collagen synthesis
09/10/2014EP2773367A1 S100 family proteins and their uses
09/10/2014EP2773366A1 Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
09/10/2014EP2773365A1 Peptide analogs for treating diseases and disorders
09/10/2014EP2773364A1 Stable pharmaceutical formulations of growth factor peptides
09/10/2014EP2773331A1 Formulations for the treatment of diabetes
09/10/2014EP2773318A2 Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
09/09/2014US8829264 Methods and compositions for RNA interference
09/09/2014US8829173 Recombinant vectors
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 3163